Focal Points with Brom Rector

3: MindMed Deep Dive. JR Rahn, LSD, Nasdaq Uplisting, Pump and Dump or To the Moon?

Listen Later

Many of us have already 10x'd our money on MindMedicine (MMED / MMEDF):  should we take our profits now or hold for the next 10 years? Brom dives deep into this topic and looks at questions like:

  • Will the Nasdaq uplisting happen? 
  • Is MindMed's drug development pipeline strong?
  • Why is MindMed associated with sketchy pump and dump groups like Departures Capital and Market Jar Media? 
  • Do they have a way to capitalize on their research?
  • WTF is Kevin O'Leary doing in a drug company? 
  • Why did JR Rahn sell his shares? 
  • Does MindMed Founder and CEO JR Rahn have the right qualifications? 
  • Is MindMed's team a winning team? 


    • Watch on YouTube

    https://www.youtube.com/playlist?list=PLSojjMXxr79FMrXF5ocZ5Qy5uEQ78FQJG


    Listen to this video on Spotify:

    https://open.spotify.com/show/1nVnMFaYNmln6fwk63B9kd


    Listen to this video on other Podcast Platforms:

    https://anchor.fm/brom1


    Brom on Instagram:  

    https://www.instagram.com/brom_qr/channel/ 


    Brom on Twitter:

    https://twitter.com/therealbrom


    Brom's personal website:

    https://brom.ai

    ...more
    View all episodesView all episodes
    Download on the App Store
    Focal Points with Brom RectorBy Brom Rector and Focalpoint Partners
    • 5
    • 5
    • 5
    • 5
    • 5

    5

    6 ratings

    More shows like Focal Points with Brom Rector

    View all
    Pivot by New York Magazine

    Pivot

    8,326 Listeners

    All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

    All-In with Chamath, Jason, Sacks & Friedberg

    8,385 Listeners